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Abstract 
Hypertension is common in Asian populations and is a major cause of cardiovascular 
diseases.  Even a small reduction in blood pressure can lead to a substantial decrease 
in the risk of stroke.  The prevalence of hypertension appears to be increasing in many 
countries, partly because of ageing of the population, but also because of increasing 
obesity.  Obesity, diabetes and hypertension are often found together, in patients who 
have the metabolic syndrome.  Diabetes, which is common in Asia, is associated with 
hypertension and so, it is important to detect and treat hypertension vigorously in 
these patients.  While much effort has gone into promoting the awareness of 
hypertension, the rates of detection, treatment and control remain low.  As 
hypertension is very prevalent in the general population, it makes sense to adopt 
population approaches towards the detection and treatment of hypertension, and its 
prevention.  As obesity is a major cause of hypertension in Asia, tackling it will help 
to lower the incidence of hypertension in the future.  Lowering sodium contents in 
foods and promotion of regular physical activity will also help to lower blood 
pressure at the population level.  Asians appear to respond well to calcium channel 
blockers but have a higher incidence of dry cough with angiotensin converting 
enzyme inhibitors.  There are now enough generic antihypertensive drugs from which 
to choose, but it is recognised that the costs of long term follow up and treatment 
impose a certain economic burden, whether on the individual or the health provider.   
[246 words] 
 
2  
 
 
Hypertension is common in Asia (Table 1)1 and is a major cause of circulatory 
diseases such as stroke, coronary heart disease, heart failure and renal failure.  Even a 
small reduction in blood pressure can lead to a substantial decrease in the risk of both 
ischaemic and haemorrhagic stroke.  
 
The prevalence of hypertension appears to be increasing in many countries,2 partly 
because of ageing of the population, but also because of increasing obesity.   In Asia, 
central or abdominal obesity is an important cause of hypertension and diabetes.3  In 
the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS), 58% of 
people with diabetes had raised blood pressure, while 56% of people with 
hypertension had dysglycaemia.4  Obesity, diabetes and hypertension are often found 
together in the same patient, who may also have hypertriglyceridaemia and reduced 
high density lipoprotein-cholesterol.  This cluster of risk factors forms the metabolic 
syndrome (Table 2).5  The syndrome, although controversial, is a useful concept in 
Asia,6 because it precedes type 2 diabetes and reminds the clinician to look for the 
other components of the syndrome. 
 
In Asia, diabetes is common,7 and presents a particular challenge.  As it is associated 
with hypertension and dyslipidaemia, the patients are at increased cardiovascular risk 
and require a comprehensive approach to the management of cardiovascular risk.  
This includes good control of blood pressure, which is known to reduce 
macrovascular complications.  The detection and vigorous treatment of hypertension 
in diabetic patients are therefore extremely important.   
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While much effort has gone into promoting the awareness of hypertension, the rates 
of detection, treatment and control remain low.  If hypertension is present in 20-30 % 
of the general population, it makes sense to adopt a population approach towards the 
detection and treatment of hypertension, and its prevention.  The high prevalence of 
hypertension justifies the measurement of blood pressure in every adult.  Because of 
the large numbers, ambulatory blood pressure cannot be used for the purpose of 
screening.  Instead, home blood pressure monitors may prove to be very useful, as 
they are increasingly affordable.  These home machines may be used in other 
household members for the detection and the monitoring of hypertension. Indeed, 
home blood pressure monitoring is now recognised as one of the methods for the 
diagnosis of hypertension in the NICE guideline on the management of hypertension 
in adults in primary care.  
 
As obesity is a major cause of hypertension and its prevalence is increasing in Asia, 
tackling it will help to lower the incidence of hypertension in the future.  In order to 
prevent the rise in blood pressure, people in the community must embrace a healthy 
lifestyle and change their diet and leisure activities to prevent the development of 
obesity (Table 3).  The prevalence of hypertension increases with age, which means 
that lifestyle changes must be started early in life.  We have identified snack foods as 
an important factor associated with obesity, and not eating vegetables, fruits and fish 
as a risk factor for diabetes.8  Lowering sodium contents in foods and promotion of 
regular physical activity will also help to lower blood pressure at the population level.  
Asian households tend to be larger than in western countries and it is common for the 
extended family or generations to live together.  This means that lifestyle changes 
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should be targeted at the household rather than the individual hypertensive patient.  A 
family approach should work well in Asia. 
 
There have been high hopes that the Human Genome Project will reveal the genes 
that cause common diseases such as hypertension.  Genome wide association studies 
have revealed many candidate genes for hypertension but nearly all of these have only 
a small effect on blood pressure.  For the majority in the general population, a large 
number of genes influence blood pressure.  This means that a single drug class is 
unlikely to be sufficient to normalise blood pressure in every person.  Asians appear 
to respond well to calcium channel blockers,9 but have a higher incidence of dry 
cough with angiotensin converting enzyme inhibitors.10  Angiotensin receptor 
blockers may be suitable for Asian patients who develop a cough with the latter.  
There are now enough generic antihypertensive drugs from which to choose, but it is 
recognised that the costs of long term follow up and treatment impose a certain 
economic burden, whether on the individual or the health provider.   
 
In conclusion, we must not underestimate the scale and depth of the challenge of 
hypertension in Asia.  It is very prevalent and increasingly so, partly because of the 
ageing of the population and partly because of increasing obesity.  We still do not 
know the main genes involved and existing antihypertensive drugs are not ideal in 
terms of efficacy and tolerability, resulting in imperfect compliance and suboptimal 
blood pressure control.  To prevent hypertension and to reduce the incidence of 
hypertension in the general population, lifestyle changes, including healthy diet and 
regular physical activity, are of paramount importance and should be taken up by 
people of all ages.   
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Table 1.  Prevalence and control of hypertension in different parts of Asia  
 
 
Region Year Prevalence (%) Control (%) 
 
    Men Women Men Women 
 
China 2002 20 17 5% (Total) 
 
Korea 2001 31.5 23.7 7.7 14.0 
 
Malaysia 1996 31.9 33.9 6.0 6.0 
 
Taiwan 2002 27.1 20.2 21.0 28.5 
 
Turkey 2003 27.5 36.1 8.2 8.0 
 
Adapted from Cheung & Ong.1  
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Table 2. Criteria for diagnosis of the metabolic syndrome 
 
Measure  Categorical Cut Points  
 
Elevated waist circumference*  Population-and country-specific definitions 
Elevated triglycerides (drug treatment  
for elevated triglycerides is an  
alternate indicator†)  
 ≥ 150 mg/dL (1.7 mmol/L)  
Reduced HDL-C (drug treatment for  
reduced HDL-C is an alternate  
indicator†)  
 < 40 mg/dL (1.0 mmol/L) in males;  
 < 50 mg/dL (1.3 mmol/L) in females  
Elevated blood pressure  
(antihypertensive drug treatment in a  
patient with a history of hypertension  
is an alternate indicator)  
Systolic ≥ 130 and/or diastolic ≥ 85 mm Hg 
Elevated fasting glucose‡ (drug  
treatment of elevated glucose is an  
 ≥ 100 mg/dL (≥ 5.6 mmol/L) 
alternate indicator)  
 
HDL-C, high-density lipoprotein cholesterol. 
*It is recommended that the International Diabetes Federation (IDF) cut points be 
used for non-Europeans and either the IDF or American Heart Association/National 
Heart, Lung and Blood Institute (AHA/NHLBI) cut points used for people of 
European origin until more data are available. 
†The most commonly used drugs for elevated triglycerides and reduced HDL-C are 
fibrates and nicotinic acid. A patient taking 1 of these drugs can be presumed to have 
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high triglycerides and low HDL-C. High-dose omega-3 fatty acids presumes high 
triglycerides. 
‡Most patients with type 2 diabetes mellitus will have the metabolic syndrome by the 
proposed criteria. 
Adapted from the joint interim statement of the International Diabetes Federation 
Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood 
Institute; American Heart Association; World Heart Federation; International 
Atherosclerosis Society; and International Association for the Study of Obesity.5  
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Table 3.  Effects of lifestyle changes on blood pressure 
 
Modification Approximate SBP reduction 
Weight reduction 5-20 mmHg/10 kg weight loss 
Dietary Approaches to Stop Hypertension 
(DASH) diet 
 
8-14 mmHg 
Low sodium diet 2-8 mmHg 
Physical activity 4-9 mmHg 
Moderating alcohol consumption 2-4 mmHg 
 
 
Adapted from The Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure produced by the 
National Heart Lung and Blood Institute, US. 
http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf [Accessed on 11. 
11. 11] 
 
 
